Compositions and methods for use in the treatment of cancer and other indications
TW202629175APending Publication Date: 2026-07-16THERAS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW114138683
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-10-07
- Filing Date
- 2025-10-07
- Publication Date
- 2026-07-16
Abstract
Provided herein are methods of treating diseases, disorders, or conditions including cancers, where the methods comprise administration of Compound 1, or a pharmaceutically acceptable salt thereof, in combination with a CDK inhibitor or a selective estrogen receptor degrader (SERD), as described herein. Such methods may comprise the treatment of cancer, such as breast cancer.
Need to check novelty before this filing date? Find Prior Art